ArticlePsychiatric services (Washington, D.C.)2012
Perceptions of the state policy environment and adoption of medications in the treatment of substance use disorders.
Article in Psychiatric services (Washington, D.C.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources.Journal of studies on alcohol and drugs · 2014Trial
- Opioid and alcohol use disorder medication availability in outpatient care: national estimates & potential policy levers.Health affairs scholar · 2025Article
- Expert Panel Consensus on State-Level Policies to Improve Engagement and Retention in Treatment for Opioid Use Disorder.JAMA health forum · 2022Article
- Medicaid Expansion and Availability of Opioid Medications in the Specialty Substance Use Disorder Treatment System.Psychiatric services (Washington, D.C.) · 2021Article
- Availability of Medications for the Treatment of Alcohol and Opioid Use Disorder in the USA.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020Review
- State criminal justice policy context and opioid agonist treatment delivery among opioid treatment admissions, 2015.Drug and alcohol dependence · 2020Article
- A Changing Landscape for Treatment of Alcohol and Drug Use Disorders.American journal of public health · 2019Article
- Barriers and Facilitators to Tobacco Cessation in a Nationwide Sample of Addiction Treatment Programs.Journal of substance abuse treatment · 2016Article
- Substance Abuse Counselors' Recovery Status and Self-Schemas: Preliminary Implications for Empirically Supported Treatment Implementation.Journal of drug and alcohol research · 2016Article
- Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.Substance abuse · 2016Article
- Service delivery and pharmacotherapy for alcohol use disorder in the era of health reform: Data from a national sample of treatment organizations.Substance abuse · 2016Article
- Longitudinal Examination of Medical Staff Utilization in Substance Use Disorder Treatment Organizations.Journal of substance abuse treatment · 2015Article
- Measures for Predictors of Innovation Adoption.Administration and policy in mental health · 2015Review
- A Longitudinal Study of State Strategies and Policies to Accelerate Evidence-Based Practices in the Context of Systems Transformation.Health services research · 2015Article
- Do preferences of drinker-drivers differ?International journal of health economics and management · 2015Article
- Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.Substance abuse treatment, prevention, and policy · 2015Article
- Innovation attributes and adoption decisions: perspectives from leaders of a national sample of addiction treatment organizations.Journal of substance abuse treatment · 2015Article
- Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs.Medical care research and review : MCRR · 2014Article
- Integrating substance abuse treatment into HIV care: missed opportunities in the AIDS Drug Assistance Program.Journal of acquired immune deficiency syndromes (1999) · 2013Article
- Disparities in access to physicians and medications for the treatment of substance use disorders between publicly and privately funded treatment programs in the United States.Journal of studies on alcohol and drugs · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
objectiveDespite growing interest in the use of evidence-based treatment practices for treating substance use disorders, adoption of medications by treatment programs remains modest. Drawing on resource dependence and institutional theory, this study examined the relationships between adoption of medications by treatment programs and their perceptions about the state policy environment.
methodsData were collected through mailed surveys and telephone interviews with 250 administrators of publicly funded substance abuse treatment programs in the United States between 2009 and 2010. Multiple imputation and multivariate logistic regression were used to estimate the associations between perceptions of the state policy environment and the odds of adopting at least one medication for the treatment of substance use disorders.
resultsA total of 91 (37%) programs reported having prescribed any medication for treatment of a substance use disorder. Programs were significantly more likely to have adopted at least one medication if they perceived greater support for medications by the Single State Agency. The odds of adoption were significantly greater if the program was aware that at least one medication was included on their state's Medicaid formulary and that state-contract funding permitted the purchase of medications.
conclusionsStates may play significant roles in promoting the adoption of medications, but adequate dissemination of information about state policies and priorities may be vital to further adoption. Future research should continue to study the relationships between the adoption of medications for treating substance use disorders and the evolving policy environment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.